Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Feinglos

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|November 30, 1983
Long-term safety and efficacy of glipizideM N Feinglos, H E Lebovitz
Diabetes Care|April 6, 1999
Oral agent therapy in the treatment of type 2 diabetesM N Feinglos, M A Bethel
The American Journal of Medicine|November 30, 1983
Mechanism of action of the second-generation sulfonylurea glipizideH E Lebovitz, M N Feinglos
Diabetes Care|March 1, 1984
Relaxation-induced improvement in glucose tolerance is associated with decreased plasma cortisolR S Surwit, M N Feinglos
Diabetes Care|January 1, 1988
Stress and autonomic nervous system in type II diabetes. A hypothesisR S Surwit, M N Feinglos
Nature|November 9, 1978
Sulphonylureas increase the number of insulin receptorsM N Feinglos, H E Lebovitz
Metabolism: Clinical and Experimental|May 1, 1980
Therapy of insulin-independent diabetes mellitus: general considerationsH E Lebovitz, M N Feinglos
The Journal of Clinical Investigation|November 1, 1977
Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of boneM K Drezner, M N Feinglos
Diabetes Care|March 1, 1983
The effects of relaxations on glucose tolerance in non-insulin-dependent diabetesR S Surwit, M N Feinglos
Comprehensive Therapy|April 1, 1979
Sulfonylurea drugs and insulin-independent diabetes mellitusH E Lebovitz, M N Feinglos
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|November 30, 1983
Long-term safety and efficacy of glipizideM N Feinglos, H E Lebovitz
Diabetes Care|April 6, 1999
Oral agent therapy in the treatment of type 2 diabetesM N Feinglos, M A Bethel
The American Journal of Medicine|November 30, 1983
Mechanism of action of the second-generation sulfonylurea glipizideH E Lebovitz, M N Feinglos
Diabetes Care|March 1, 1984
Relaxation-induced improvement in glucose tolerance is associated with decreased plasma cortisolR S Surwit, M N Feinglos
Diabetes Care|January 1, 1988
Stress and autonomic nervous system in type II diabetes. A hypothesisR S Surwit, M N Feinglos
Nature|November 9, 1978
Sulphonylureas increase the number of insulin receptorsM N Feinglos, H E Lebovitz
Metabolism: Clinical and Experimental|May 1, 1980
Therapy of insulin-independent diabetes mellitus: general considerationsH E Lebovitz, M N Feinglos
The Journal of Clinical Investigation|November 1, 1977
Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of boneM K Drezner, M N Feinglos
Diabetes Care|March 1, 1983
The effects of relaxations on glucose tolerance in non-insulin-dependent diabetesR S Surwit, M N Feinglos
Comprehensive Therapy|April 1, 1979
Sulfonylurea drugs and insulin-independent diabetes mellitusH E Lebovitz, M N Feinglos
Pageof 7